Samantha M. Doonan
New York State Office of Addiction Services and Supports (OASAS) - Science Policy Fellow
Email: Samantha.Doonan@oasas.ny.gov
Education
PhD, Population Health, New York University Grossman School of MedicineBA, Health: Science, Society & Policy; Psychology, Brandeis University
Research Interests
Cannabis policy, cannabis legalization, health equity, opioid policy, social determinants of health BIO
Samantha Doonan (she/her) is a New York State Science Policy Fellow in the New York State Office of Addiction Services and Supports. She holds a PhD in Population Health from the New York University Grossman School of Medicine. Her research focuses on the impact of state substance use policies on population health and equity. Previously, she conducted research for the Massachusetts Cannabis Control Commission and worked as a health science specialist for the Veteran Affairs National Center for PTSD. Publications
Recent
Doonan SM, Joshi S, Choi S, Adhikari S, Davis CS, Cerda M (2025).
Examining the association between county racialised economic segregation and fatal overdose in US counties, 2018-2022
Journal of Epidemiology and Community Health [Epub 2025 Oct 31]. doi: 10.1136/jech-2025-224452.
Examining the association between county racialised economic segregation and fatal overdose in US counties, 2018-2022
Journal of Epidemiology and Community Health [Epub 2025 Oct 31]. doi: 10.1136/jech-2025-224452.
Mannes ZL, Nowels M, Mauro C, Cook S, Wheeler-Martin K, Gutkind S, Bruzelius E, Doonan SM, Crystal S, Davis CS, Samples H, Hasin DS, Keyes KM, Rudolph KE, Cerda M, Martins SS (2025).
The combined relationship of prescription drug monitoring program enactment and medical cannabis laws with chronic pain-related healthcare visits
Journal of General Internal Medicine, 40 (5), 1030-1038. doi: 10.1007/s11606-024-09053-6. PMCID: PMC11968579.
The combined relationship of prescription drug monitoring program enactment and medical cannabis laws with chronic pain-related healthcare visits
Journal of General Internal Medicine, 40 (5), 1030-1038. doi: 10.1007/s11606-024-09053-6. PMCID: PMC11968579.
Doonan SM, Wheeler-Martin K, Davis C, Mauro C, Bruzelius E, Crystal S, Mannes Z, Gutkind S, Keyes KM, Rudolph KE, Samples H, Henry SG, Hasin DS, Martins SS, Cerda M (2025).
How do restrictions on opioid prescribing, harm reduction, and treatment coverage policies relate to opioid overdose deaths in the United States in 2013-2020? An application of a new state opioid policy scale
International Journal of Drug Policy, 137, 104713. doi: 10.1016/j.drugpo.2025.104713. PMCID: PMC11875926.
How do restrictions on opioid prescribing, harm reduction, and treatment coverage policies relate to opioid overdose deaths in the United States in 2013-2020? An application of a new state opioid policy scale
International Journal of Drug Policy, 137, 104713. doi: 10.1016/j.drugpo.2025.104713. PMCID: PMC11875926.
Joshi S, Doonan SM, Pamplin JR (2023).
A tale of two cities: Racialized arrests following decriminalization and recreational legalization of cannabis
Drug and Alcohol Dependence, 249, 109911. doi: 10.1016/j.drugalcdep.2023.109911.
A tale of two cities: Racialized arrests following decriminalization and recreational legalization of cannabis
Drug and Alcohol Dependence, 249, 109911. doi: 10.1016/j.drugalcdep.2023.109911.
Doonan SM, Johnson JK, Firth C, Flores A, Joshi S (2022).
Racial equity in cannabis policy: Diversity in the Massachusetts adult-use industry at 18-months
Cannabis, 5 (1), 30-41. doi: 10.26828/cannabis/2022.01.004. PMCID: PMC10212236.
Ms. Doonan's Google Scholar Profile
Racial equity in cannabis policy: Diversity in the Massachusetts adult-use industry at 18-months
Cannabis, 5 (1), 30-41. doi: 10.26828/cannabis/2022.01.004. PMCID: PMC10212236.